Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the suppression of ovarian function trial (SOFT): The SOFT-EST substudy

1. Bellet, M.
2. Gray, K.P.
3. Francis, P.A.
4. Láng, I.
5. Ciruelos, E.
6. Lluch, A.
7. Climent, M.A.
8. Catalán, G.
9. Avella, A.
10. Bohn, U.
11. González-Martin, A.
12. Ferrer, R.
13. Catalán, R.
14. Azaro, A.
15. Rajasekaran, A.
16. Morales, J.
17. Vázquez, J.
18. Fleming, G.F.
19. Price, K.N.
20. Regan, M.M.